BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zeng KY, Bao WYG, Wang YH, Liao M, Yang J, Huang JY, Lu Q. Non-invasive evaluation of liver steatosis with imaging modalities: New techniques and applications. World J Gastroenterol 2023; 29(17): 2534-2550 [PMID: 37213404 DOI: 10.3748/wjg.v29.i17.2534]
URL: https://www.wjgnet.com/2150-5330/full/v29/i17/2534.htm
Number Citing Articles
1
Bianca M. Leca, Lukasz Lagojda, Chris Kite, Emmanouil Karteris, Eva Kassi, Harpal S. Randeva, Ioannis Kyrou. Maternal obesity and metabolic (dysfunction) associated fatty liver disease in pregnancy: a comprehensive narrative review.Expert Review of Endocrinology & Metabolism 2024;  doi: 10.1080/17446651.2024.2365791
2
Pihou Gbande, Mazamaesso Tchaou, Huguette Diane Djoko Makamto, Massaga Dagbe, Lantam Sonhaye, Lama Kegdigoma Agoda-Koussema, Komlanvi Adjenou. Correlation between qualitative and semi-quantitative ultrasound assessment of diffuse fatty liver disease: A case-control studyUltrasound 2024;  doi: 10.1177/1742271X241241779
3
Zhi Xin Tan, Bryan Mehta, Kieran Kusel, James Seow, Marilyn Zelesco, Steven Abbott, Rebecca Simons, Glenn Boardman, Christopher J. Welman, Oyekoya T. Ayonrinde. Hepatic steatosis: Qualitative and quantitative sonographic assessment in comparison to histologyAustralasian Journal of Ultrasound in Medicine 2024;  doi: 10.1002/ajum.12381
4
Andrzej S Tarnawski. Editor-in-Chief articles of choice and comments at the year-end of 2023World Journal of Gastroenterology 2024; 30(1): 1-8 doi: 10.3748/wjg.v30.i1.1
5
Jeongmin Lee, Seung-Hwan Lee. Expanding the therapeutic landscape: ezetimibe as non-statin therapy for dyslipidemiaThe Korean Journal of Internal Medicine 2023; 38(6): 797 doi: 10.3904/kjim.2023.243
6
Yan Zhou, Mengjin Nie, Hongyu Zhou, Feng Mao, Lin Zhao, Jianmin Ding, Xiang Jing. Head-to-head comparison of three different US-based quantitative parameters for hepatic steatosis assessment: a prospective studyAbdominal Radiology 2024;  doi: 10.1007/s00261-024-04347-z
7
Xinlu Cao, Oksana Zolnikova, Roman Maslennikov, Maria Reshetova, Elena Poluektova, Arina Bogacheva, Maria Zharkova, Vladimir Ivashkin. Low Short-Chain-Fatty-Acid-Producing Activity of the Gut Microbiota Is Associated with Hypercholesterolemia and Liver Fibrosis in Patients with Metabolic-Associated (Non-Alcoholic) Fatty Liver DiseaseGastrointestinal Disorders 2023; 5(4): 464 doi: 10.3390/gidisord5040038
8
Pál Novák Kaposi, Zita Zsombor, Aladár D. Rónaszéki, Bettina K. Budai, Barbara Csongrády, Róbert Stollmayer, Ildikó Kalina, Gabriella Győri, Viktor Bérczi, Klára Werling, Pál Maurovich-Horvat, Anikó Folhoffer, Krisztina Hagymási. The Calculation and Evaluation of an Ultrasound-Estimated Fat Fraction in Non-Alcoholic Fatty Liver Disease and Metabolic-Associated Fatty Liver DiseaseDiagnostics 2023; 13(21): 3353 doi: 10.3390/diagnostics13213353
9
Aldo Rocca, Klara Komici, Maria Chiara Brunese, Giulia Pacella, Pasquale Avella, Chiara Di Benedetto, Corrado Caiazzo, Marcello Zappia, Luca Brunese, Gianfranco Vallone. Quantitative ultrasound (QUS) in the evaluation of liver steatosis: data reliability in different respiratory phases and body positionsLa radiologia medica 2024; 129(4): 549 doi: 10.1007/s11547-024-01786-y
10
Marinela Sînziana Tudor, Veronica Gheorman, Georgiana-Mihaela Simeanu, Adrian Dobrinescu, Vlad Pădureanu, Venera Cristina Dinescu, Mircea-Cătălin Forțofoiu. Evolutive Models, Algorithms and Predictive Parameters for the Progression of Hepatic SteatosisMetabolites 2024; 14(4): 198 doi: 10.3390/metabo14040198